Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06956755 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv3
  2. Primary endpoints revised (9)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Trial Details
NCT Number NCT06956755
Lead Sponsor Groupe Francophone des Myelodysplasies
Conditions
(from sponsor)		 Myelodysplastic Syndromes, Leukemia, Myeloid, Acute
Related terms Leukemia, Myeloid, Acute, Myelodysplastic Syndromes
Enrollment 6,990 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov